Late Onset Alzheimer's Disease

Last updated: May 15, 2024
Sponsor: Columbia University
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

Blood Draw

Late Onset Alzheimer's Disease (LOAD) Neuropsychological Battery Test

Clinical Study ID

NCT05010603
AAAP0479
1U24AG056270
  • Ages > 55
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The goal of this study is to is to focus on the genetic influences on Alzheimer's Disease (AD) risk. The investigators are looking for families and/or individuals (affected or unaffected) of any ethic background (African American, Caucasian, and Hispanics) with a family history of AD and willing to participate.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Established diagnosis of definite or probable AD or have a diagnosis of a relatedneurodegenerative disorder such as Frontotemporal Dementia (FTD) or Lewy BodyDementia (LBD) (will also recruit sporadic FTD and LBD) cases.

  • a living sibling with probable or possible AD;

  • a third living relative affected with AD (onset age 50 or older) or unaffected (60or older);

  • participants in the proband's generation with an identified companion serving as aninformant;

  • participants who have capacity to consent or participants lacking capacity toconsent with a surrogate/proxy in place to provide consent.

Exclusion

Exclusion Criteria:

  • failure to identify an appropriate informant;

  • uncertainty of the clinical diagnosis of Alzheimer's disease or other relateddisorder;

  • discovery of additional diagnosis that could account for the clinicalmanifestations;

  • unwillingness to participate;

  • failure to identify a living sibling with AD or other related disorder (except inthe cases of sporadic FTD and sporadic LBD);

  • participants lacking the capacity to consent who do not have a surrogate or proxy ornext of kin to provide consent.

Study Design

Total Participants: 10000
Treatment Group(s): 2
Primary Treatment: Blood Draw
Phase:
Study Start date:
November 15, 2016
Estimated Completion Date:
September 30, 2026

Study Description

The purpose of this study is to focus on the genetic influences on Alzheimer's disease (AD) risk. Specifically, the investigators hypothesize that one or more genes, other than the previously identified susceptibility gene apolipoprotein-E (APOE), or the 3 genes associated with early-onset familial AD, presenilin-1 (PS-1), presenilin-2 (PS-2) or B-amyloid precursor protein (APP), increase the risk of AD in families with multiple individuals affected with AD. The investigators propose to test this hypothesis by performing genetic linkage analysis in order to detect the chromosomal location of genes that may increase the risk of Alzheimer's disease. In addition, the investigators will study genes known to increase the risk of Alzheimer's disease and other related disorders such as early onset AD, Pick disease, corticobasal degeneration, progressive supranuclear palsy, and familial frontotemporal dementia with parkinsonism and Lewy Body Dementia.

Connect with a study center

  • University of Washington

    Washington, District of Columbia 98105
    United States

    Active - Recruiting

  • University of Miami

    Miami, Florida 33124
    United States

    Active - Recruiting

  • Rush University

    Aurora, Illinois 60612
    United States

    Active - Recruiting

  • Indiana University

    Bloomington, Indiana 47405
    United States

    Active - Recruiting

  • NCRAD at Indiana University

    Indianapolis, Indiana 46202
    United States

    Active - Recruiting

  • Mayo Clinic

    Rochester, Minnesota 55901
    United States

    Active - Recruiting

  • Joanne Norton

    Saint Louis, Missouri 63130
    United States

    Active - Recruiting

  • Columbia University Irving Medical Center

    New York, New York 10032
    United States

    Active - Recruiting

  • North Carolina State University

    Raleigh, North Carolina 27695
    United States

    Active - Recruiting

  • University of Pittsburgh

    Pittsburgh, Pennsylvania 15213
    United States

    Active - Recruiting

  • University of Texas Southwestern

    Dallas, Texas 75390
    United States

    Active - Recruiting

  • University of Washington

    Seattle, Washington 98195
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.